Japan Tissue Engineering Co (TSE:7774) OCF Yield %: -1.39 (As of Aug. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:7774 Japan Tissue Engineering Co Ltd TSE:7774
58 GF Score
Price 円862.00
GF Value 円505.19
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Japan Tissue Engineering Co OCF Yield %?

Japan Tissue Engineering Co TSE:7774 +3.61% 58 OCF Yield % is -1.39 as of Aug. 24, 2026. GuruFocus rates TSE:7774 with a GF Score™ of 58/100 and a GF Value™ of 円505.19 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 1,410 Biotechnology companies, Japan Tissue Engineering Co ranks better than 73.9% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Japan Tissue Engineering Co's Trailing 12-Month Cash Flow from Operations is 円0 Mil, and Market Cap is 円35,006 Mil. Therefore, Japan Tissue Engineering Co's OCF Yield % for today is -1.39%.

The historical rank and industry rank for Japan Tissue Engineering Co's OCF Yield % or its related term are showing as below:

TSE:7774' s OCF Yield % Range Over the Past 10 Years
Min: -1.39   Med: 0   Max: -1.39
Current: -1.39


During the past 13 years, the highest OCF Yield % of Japan Tissue Engineering Co was -1.39%. The lowest was -1.39%. And the median was %.

TSE:7774's OCF Yield % is ranked better than
73.9% of 1410 companies
in the Biotechnology industry
Industry Median: -8.435 vs TSE:7774: -1.39

Japan Tissue Engineering Co's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Japan Tissue Engineering Co OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Japan Tissue Engineering Co OCF Yield % Related Terms


Japan Tissue Engineering Co OCF Yield % Historical Data

* Premium members only.

The historical data trend for Japan Tissue Engineering Co's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Japan Tissue Engineering Co OCF Yield % Chart

Japan Tissue Engineering Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.08 -2.94 1.01 -0.80 -2.02

Japan Tissue Engineering Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

TSE:7774 vs VRTX, REGN, RVMD: OCF Yield % Comparison

For the Biotechnology subindustry, Japan Tissue Engineering Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Tissue Engineering Co OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's OCF Yield % falls into.


TSE:7774
58GF Score
Japan Tissue Engineering Co Ltd TSE:7774
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Japan Tissue Engineering Co OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Japan Tissue Engineering Co's OCF Yield % for the fiscal year that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-488.02 / 24203.56
=-2.02%

Japan Tissue Engineering Co's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=0 * 4 / 24203.56
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -1.39 mean?
Japan Tissue Engineering Co (TSE:7774) has a OCF Yield % of -1.39 as of Aug. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Japan Tissue Engineering Co and its competitors. According to the industry distribution chart, Japan Tissue Engineering Co ranks #368 out of 1410 companies in the Biotechnology industry, placing it in the top 26.1%.
Is Japan Tissue Engineering Co's OCF Yield % too high?
Japan Tissue Engineering Co's current OCF Yield % is -1.39. Based on the distribution chart, Japan Tissue Engineering Co ranks #368 out of 1410 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Japan Tissue Engineering Co has a GF Score™ of 58/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Japan Tissue Engineering Co's OCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Japan Tissue Engineering Co ranks #368 out of 1410 companies for OCF Yield %. This puts Japan Tissue Engineering Co in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Japan Tissue Engineering Co and its competitors. Japan Tissue Engineering Co's current OCF Yield % is -1.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Tissue Engineering Co stock overvalued right now?
Based on GuruFocus' analysis, Japan Tissue Engineering Co (TSE:7774) is currently considered Significantly Overvalued. The stock's GF Value™ is 円505.19, compared to a current price of 円862.00 — trading 70.6% above its estimated fair value. The current OCF Yield % is -1.39. Japan Tissue Engineering Co's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Japan Tissue Engineering Co (TSE:7774), the current OCF Yield % is -1.39 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Japan Tissue Engineering Co (TSE:7774) Overvalued in 2026?

Based on GuruFocus' analysis, Japan Tissue Engineering Co stock appears to be overvalued. The current stock price of 円862.00 is trading 70.6% above its estimated GF Value™ of 円505.19. GuruFocus considers Japan Tissue Engineering Co to be Significantly Overvalued.

Key valuation signals for TSE:7774:

  • OCF Yield %: -1.39
  • GF Value™: 円505.19 vs. price of 円862.00 (70.6% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the TSE:7774 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Japan Tissue Engineering Co Business Description

Address 6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.
58GF Score

Get the complete analysis for TSE:7774

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円862.00
Price
円505.19
GF Value